3 Pistons Maker, Engineered Plastics Maker and Diagnostic Labs Chain Stocks With a Strong Future Roadmap: SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs
- November 19, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs: ROE of 19.1% to 23.7% and FY22 to FY26 revenue CAGR of 7.6% to 21.6%. Prices as of 18 Nov 2026.
Quick Answer
The three engine piston, moulded plastic and lab stocks to watch are SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs. Their return on equity ranges from 19.1% to 23.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.6%. Shaily Engineering Plastics has the highest return on equity at 23.7%, while SPR Auto Technologies has the fastest revenue growth at 21.6% a year. Prices are based on the 18 November 2026 close, and this article is educational, not investment advice.
Engine piston, moulded plastic and lab stocks give investors a way to track businesses that sit close to everyday demand in India. SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs cover a pistons maker, an engineered plastics maker and a diagnostic labs chain.
This list covers three engine piston, moulded plastic and lab stocks with complete current figures: SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs. Every figure comes from the latest reported financials and the 18 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Engine Piston, Moulded Plastic and Lab Stocks?
Engine piston, moulded plastic and lab stocks are listed companies that make pistons and engine parts for vehicles, make moulded plastic parts for cars and appliances, and run diagnostic labs and collection centres. Their earnings depend on vehicle output, appliance orders and test volumes.
Engine Piston, Moulded Plastic and Lab Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| SPR Auto Technologies | 4,287.7 | 21,451 | 37.3 | 36.9 | 19.1 | 0.68 |
| Shaily Engineering Plastics | 3,100.6 | 13,693 | 77.5 | 35.6 | 23.7 | 0.25 |
| Dr. Lal PathLabs | 1,965.4 | 30,949 | 56.6 | 59.6 | 20.1 | 0.08 |
On valuation, Dr. Lal PathLabs trades at a P/E below the industry P/E, while SPR Auto Technologies and Shaily Engineering Plastics trade above it, which reflects the growth the market already expects. Readers comparing engine piston, moulded plastic and lab stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in engine piston, moulded plastic and lab stocks can use the coming numbers to test whether growth is holding.
Why Do Engine Piston, Moulded Plastic and Lab Stocks Have a Strong Roadmap in India?
Engine piston, moulded plastic and lab stocks have a strong roadmap in India because steady vehicle output, steady appliance and vehicle orders and wider access to tests keep widening the market for these companies.
- Pistons. Every engine needs precision pistons.
- Engineered plastics. Makers need moulded parts.
- Diagnostic labs. Doctors order more tests.
Why SPR Auto Technologies Features Among These Engine Piston, Moulded Plastic and Lab Stocks
Among the engine piston, moulded plastic and lab stocks on this list, SPR Auto Technologies, earlier known as Shriram Pistons & Rings, makes pistons, piston rings, pins and engine parts for vehicles, tractors, stationary engines and the aftermarket.
In the June 2026 quarter, revenue grew 51.2% year on year to Rs 1,499 crore, while net profit rose 9.5% to Rs 148 crore. Revenue rose from Rs 2,094 crore in FY22 to Rs 4,571 crore in FY26, a compound annual growth rate of 21.6%.
Net profit grew from Rs 164 crore in FY22 to Rs 561 crore in FY26, which works out to a compound annual growth rate of 36.1%. The company has a return on equity of 19.1%, a debt to equity ratio of 0.68 and a market capitalisation of Rs 21,451 crore. The stock trades at a P/E of 37.3, above the industry P/E of 36.9.
Roadmap: The company supplies leading vehicle makers and sells through the aftermarket, which gives it a balanced customer mix. Expansion in engine components, along with new electric vehicle-ready products, supports future growth.
What to watch: Watch the original equipment demand trend and the share of aftermarket and exports in revenue.
Why Shaily Engineering Plastics Features Among These Engine Piston, Moulded Plastic and Lab Stocks
Among the vehicle piston maker, injection moulding and diagnostics shares on this list, Shaily Engineering Plastics makes precision injection moulded plastic components, including parts for medical drug-delivery devices, consumer products and automobiles, mainly for global customers.
The company has a return on equity of 23.7%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 13,693 crore. The stock trades at a P/E of 77.5, above the industry P/E of 35.6.
Revenue rose from Rs 577 crore in FY22 to Rs 998 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 35.3 crore in FY22 to Rs 170 crore in FY26, which works out to a compound annual growth rate of 48.2%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 281 crore, while net profit rose 16.8% to Rs 48.0 crore.
Roadmap: The company is expanding in healthcare and consumer components, where global brands outsource complex moulding to trusted makers. Added capacity and new customer programmes support its order flow.
What to watch: Watch new customer programmes in drug-delivery devices and the pace of capacity additions.
Why Dr. Lal PathLabs Features Among These Engine Piston, Moulded Plastic and Lab Stocks
Among the three companies on this list, Dr. Lal PathLabs is one of India’s best-known diagnostics companies, operating a national reference laboratory with a hub-and-spoke network of labs, patient service centres and collection points.
Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%.
In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P/E of 56.6, below the industry P/E of 59.6.
Roadmap: Its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.
What to watch: Follow test volumes per patient and the balance between routine and specialised tests.
SPR Auto Technologies vs Shaily Engineering Plastics vs Dr. Lal PathLabs on Key Financials
The table below sets the three engine piston, moulded plastic and lab stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| SPR Auto Technologies | 2,094 | 4,571 | 21.6% | 561 | 12.3% |
| Shaily Engineering Plastics | 577 | 998 | 14.7% | 170 | 17.0% |
| Dr. Lal PathLabs | 2,140 | 2,864 | 7.6% | 510 | 17.8% |
Shaily Engineering Plastics posts the highest return on equity in this group at 23.7%. SPR Auto Technologies combines the largest FY26 revenue at Rs 4,571 crore with the fastest revenue growth, a 21.6% compound annual rate. A useful habit with engine piston, moulded plastic and lab stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several pistons, engineered plastics and diagnostic labs stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| SPR Auto Technologies | 992 | 1,499 | 51.2% |
| Shaily Engineering Plastics | 249 | 281 | 12.9% |
| Dr. Lal PathLabs | 698 | 830 | 18.9% |
Key Risks to Check Before Investing in Engine Piston, Moulded Plastic and Lab Stocks
Every theme carries risks that deserve a check before any decision. For these engine piston, moulded plastic and lab stocks, the main points are: Long-term vehicle piston maker, injection moulding and diagnostics shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio. Tracking promoter holding and management commentary adds context when you study vehicle piston maker, injection moulding and diagnostics shares.
- Demand cycles. Sales can vary with seasons and rates.
- Order timing. Project awards can shift between periods.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter engine piston, moulded plastic and lab stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Engine Piston, Moulded Plastic and Lab Stocks
Engine piston, moulded plastic and lab stocks work best when investors track growth, valuation and return on equity side by side. SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs each have a clear plan to grow. Based on the 18 November 2026 close, SPR Auto Technologies trades at Rs 4,287.7, Shaily Engineering Plastics at Rs 3,100.6 and Dr. Lal PathLabs at Rs 1,965.4. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these engine piston, moulded plastic and lab stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track engine piston, moulded plastic and lab stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are engine piston, moulded plastic and lab stocks?
Ans. Engine piston, moulded plastic and lab stocks are listed companies that make pistons and engine parts for vehicles, make moulded plastic parts for cars and appliances, and run diagnostic labs and collection centres. Their earnings depend on vehicle output, appliance orders and test volumes. This list looks at three of them, SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.
Which engine piston, moulded plastic and lab stocks are covered in this list?
Ans. This list covers SPR Auto Technologies, Shaily Engineering Plastics and Dr. Lal PathLabs. Based on the 18 November 2026 close, SPR Auto Technologies traded at Rs 4,287.7, Shaily Engineering Plastics at Rs 3,100.6 and Dr. Lal PathLabs at Rs 1,965.4. Their return on equity ranges from 19.1% to 23.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.6%.
Why do engine piston, moulded plastic and lab stocks have a strong future roadmap in India?
Ans. Engine piston, moulded plastic and lab stocks have a strong roadmap in India because steady vehicle output, steady appliance and vehicle orders and wider access to tests keep widening the market for these companies. The main drivers are as follows. Pistons. Every engine needs precision pistons. Engineered plastics. Makers need moulded parts. Diagnostic labs. Doctors order more tests. Together these factors give the companies on this list a visible path for growth over the coming years.
How has SPR Auto Technologies performed financially?
Ans. Revenue rose from Rs 2,094 crore in FY22 to Rs 4,571 crore in FY26, a compound annual growth rate of 21.6%. Net profit grew from Rs 164 crore in FY22 to Rs 561 crore in FY26, which works out to a compound annual growth rate of 36.1%. In the June 2026 quarter, revenue grew 51.2% year on year to Rs 1,499 crore, while net profit rose 9.5% to Rs 148 crore. The company has a return on equity of 19.1%, a debt to equity ratio of 0.68 and a market capitalisation of Rs 21,451 crore. The stock trades at a P/E of 37.3, above the industry P/E of 36.9. Looking ahead, the company supplies leading vehicle makers and sells through the aftermarket, which gives it a balanced customer mix. Expansion in engine components, along with new electric vehicle-ready products, supports future growth.
How has Shaily Engineering Plastics performed financially?
Ans. Revenue rose from Rs 577 crore in FY22 to Rs 998 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 35.3 crore in FY22 to Rs 170 crore in FY26, which works out to a compound annual growth rate of 48.2%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 281 crore, while net profit rose 16.8% to Rs 48.0 crore. The company has a return on equity of 23.7%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 13,693 crore. The stock trades at a P/E of 77.5, above the industry P/E of 35.6. Looking ahead, the company is expanding in healthcare and consumer components, where global brands outsource complex moulding to trusted makers. Added capacity and new customer programmes support its order flow.
How has Dr. Lal PathLabs performed financially?
Ans. Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P/E of 56.6, below the industry P/E of 59.6. Looking ahead, its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.
What risks should investors check before buying engine piston, moulded plastic and lab stocks?
Ans. Investors should check a few risks before buying engine piston, moulded plastic and lab stocks. Demand cycles. Sales can vary with seasons and rates. Order timing. Project awards can shift between periods. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of engine piston, moulded plastic and lab stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.